Drug Enforcement D-0653-2024

Lack of Assurance of Sterility

Status

Ongoing

Classification

Class II

Report Date

September 11, 2024

Termination Date

—

Product Information

Product description
SEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-04
Product quantity
1,960 vials
Reason for recall
Lack of Assurance of Sterility
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA

Location & Firm

Recalling firm
ProRx LLC
Address
619 Jeffers Cir

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0653-2024
Event ID
95190
Recall initiation date
August 22, 2024
Center classification date
September 5, 2024
Code info
ProRx061424, BUD 12/13/2024
More code info
—